carmustine has been researched along with Carcinoma, Brown-Pearce in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Carcinoma, Brown-Pearce: A transplantable EPITHELIAL CELL neoplasm of rabbits.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HS | 2 |
| Refojo, MF | 2 |
| Perry, HD | 2 |
| Albert, DM | 2 |
2 other studies available for carmustine and Carcinoma, Brown-Pearce
| Article | Year |
|---|---|
Sustained release of BCNU for the treatment of intraocular malignancies in animal models.
Topics: Animals; Anterior Chamber; Carcinoma, Brown-Pearce; Carmustine; Drug Implants; Ethanol; Eye Neoplasm | 1979 |
Direct delivery of anticancer agents: experimental treatment of intraocular malignancy.
Topics: Animals; Anterior Chamber; Carcinoma, Brown-Pearce; Carmustine; Conjunctiva; Dacarbazine; Eye Neopla | 1978 |